D. H. F. de Oliveira et al., “SEMAGLUTIDE AND TIRZEPATIDE IN THE TREATMENT OF OBESITY: BENEFITS, RISKS, AND CLINICAL PERSPECTIVES OF GLP-1 RECEPTOR AGONISTS”, REASE, vol. 12, no. 6, pp. 1–17, Jun. 2026, doi: 10.51891/rease.v12i6.28619.